Lanka Hospitals Corp. Plc (LHCL.N0000) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Lanka Hospitals Corp. Plc has changed its score on 03 Dec 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 25.53% of over the last 5 years

Flat results in Dec 24

With ROE of 11.03%, it has a expensive valuation with a 1.46 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

LKR 24,107 Million (Mid Cap)

P/E

13.00

Industry P/E

Dividend Yield

0.09%

Debt Equity

-0.64

Return on Equity

11.75%

Price to Book

1.60

Revenue and Profits:

Net Sales:

3,372 Million

(Quarterly Results - Dec 2024)

Net Profit:

566 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

21.58%

6 Months

29.09%

1 Year

34.64%

2 Years

-15.81%

3 Years

5.71%

4 Years

95.41%

5 Years

136.67%

Lanka Hospitals Corp. Plc for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.93%

EBIT Growth (5y)

25.53%

EBIT to Interest (avg)

58.10

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.60

Sales to Capital Employed (avg)

0.93

Tax Ratio

24.43%

Dividend Payout Ratio

25.06%

Pledged Shares

Institutional Holding

ROCE (avg)

42.68%

ROE (avg)

15.42%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.46

EV to EBIT

4.38

EV to EBITDA

3.39

EV to Capital Employed

2.22

EV to Sales

0.89

PEG Ratio

Dividend Yield

0.10%

ROCE (Latest)

50.59%

ROE (Latest)

11.03%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -0.45% vs -3.91% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 116.65% vs -51.04% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,372.00",
          "val2": "3,387.20",
          "chgp": "-0.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,025.90",
          "val2": "850.70",
          "chgp": "20.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.30",
          "val2": "15.60",
          "chgp": "-8.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "565.90",
          "val2": "261.20",
          "chgp": "116.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "247.40%",
          "val2": "191.40%",
          "chgp": "5.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.92% vs 16.08% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -0.43% vs -58.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,650.10",
          "val2": "12,418.60",
          "chgp": "9.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,640.50",
          "val2": "3,058.20",
          "chgp": "19.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.90",
          "val2": "33.00",
          "chgp": "75.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,339.40",
          "val2": "1,345.20",
          "chgp": "-0.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "210.80%",
          "val2": "192.10%",
          "chgp": "1.87%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ

Dec'24

Sep'24

Change(%)

Net Sales

3,372.00

3,387.20

-0.45%

Operating Profit (PBDIT) excl Other Income

1,025.90

850.70

20.59%

Interest

14.30

15.60

-8.33%

Exceptional Items

0.00

Consolidate Net Profit

565.90

261.20

116.65%

Operating Profit Margin (Excl OI)

247.40%

191.40%

5.60%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2024 is -0.45% vs -3.91% in Sep 2024

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 116.65% vs -51.04% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

13,650.10

12,418.60

9.92%

Operating Profit (PBDIT) excl Other Income

3,640.50

3,058.20

19.04%

Interest

57.90

33.00

75.45%

Exceptional Items

0.00

Consolidate Net Profit

1,339.40

1,345.20

-0.43%

Operating Profit Margin (Excl OI)

210.80%

192.10%

1.87%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 9.92% vs 16.08% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -0.43% vs -58.57% in Dec 2023

All Annual Results

Company CV

About Lanka Hospitals Corp. Plc

Lanka Hospitals Corp. Plc

Hospital

The Lanka Hospitals Corporation PLC is a tertiary care hospital in Sri Lanka, which is engaged in providing healthcare solutions. The Company's principal activity is to provide healthcare and laboratory services. It specializes in a range of procedures from conventional to minimally invasive surgeries. The Company offers various medical services, including emergency services, heart center, renal care, hemato-oncology, fertility center, kidney care center, vaccinations, surgical department, radiology services, eye clinic, mother and baby care, dental clinic, physiotherapy, dermatology, gastroenterology and neurosciences, among others. The Company, through its diagnostic laboratory, Lanka Hospitals Diagnostics (LHD), offers a range of diagnostic facilities, including fields, such as hematology, histopathology, chemical pathology, microbiology, molecular diagnostics, cytogenetics and flow cytometry. The Company's subsidiary is Lanka Hospitals Diagnostics (Private) Limited.

Company Coordinates

Company Details

No.578, Elvitigala Mawatha, Narahenpita, Colombo 05 COLOMBO None : 05

Tel: 94 11 5530000

http://www.lankahospitals.com/

Registrar Details